Skip to content

Clinical trials

Completed Phase 1/2 Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Phase 1/2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20061
20072
20082
20092
20101
20112
20142
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Mayo Clinic2
Acrotech Biopharma Inc.1
Asan Medical Center1
Cancer Treatment Centers of America1
Celgene1
Fondazione Italiana Linfomi - ETS1
M.D. Anderson Cancer Center1
Massachusetts General Hospital1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy18
Lymphoma, Large-Cell, Anaplastic16
Hodgkin Disease11
Lymphoma, B-Cell, Marginal Zone11
Lymphoma, Follicular11
Lymphoma, Large B-Cell, Diffuse11
Lymphoma, Mantle-Cell11
Waldenstrom Macroglobulinemia11
Burkitt Lymphoma10
Leukemia, Lymphocytic, Chronic, B-Cell10

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.